newsfilter
← Latest News
Business Wire·

Cortexyme Provides Business Update and Reports First Quarter 2021 Results

Top-line data from 643-subject Alzheimer's disease pivotal GAIN Trial expected in fourth quarter 2021 Top-line data from 233-subject periodontal disease Phase 2 REPAIR sub-study of the GAIN Trial expected in fourth quarter 2021 COR588 on trac